Founded by industry veterans in 2019, Curavit is purpose-built to deliver the future of clinical research to innovative clients in biotech, academic research, and digital therapeutics.
Curavit is a Leader
in the Design and
Execution of Decentralized
Clinical Trials
About Decentralized Clinical Trials
Decentralized – also called “virtual” – clinical trials eliminate the complexity of traditional trials’ heavy, multi-site footprint with a virtual meta-site, which can access patients anywhere, monitor them remotely through tele-health and wearable technologies, and apply modern data science to the larger, more robust data sets that result.
We Design
and Execute Decentralized
Clinical Trials
Curavit is a “virtual CRO”, purpose-built to design and execute decentralized clinical trials. We work with our clients to design their trials from first principles, based on our team’s decades of experience in research and digital health technologies. For each trial, we assign an experienced principal investigator, who is an expert in the specific disease area, to develop the protocol and drive the regulatory submission process. We manage participant recruitment, enrollment, and consent. Under the direction of the PI, our clinical study team executes the entire decentralized clinical trial. Our single, virtual meta-site leverages our proprietary clinical trial management platform, supports remote monitoring, and is always audit-ready.
Leadership Team
Joel Morse
CEO
Joel Morse is an experienced operational CEO who has founded, built, and sold large global businesses in healthcare and life sciences. He is founder of Curavit, and serves as its CEO.
Pam Diamond
CMO
Dr. Diamond is a Board Certified, Boston-based Otolaryngologist/Head and Neck Surgeon who was affiliated with Harvard Medical School (HMS) and Massachusetts Eye and Ear Infirmary (MEEI) for over 30 years.
Dave Hanaman
CCO
Dave Hanaman is President and Chief Commercial Officer of Curavit, a digital-health clinical trials company he co-founded. He is a proven entrepreneur, operator, and board director with successful, strategic exits to public companies.
Jay Collier
COO
As chief operating officer (COO), Jay is responsible for managing all aspects of service delivery for Curavit’s clients. Jay has has over 20 years of operational experience serving global clients in life sciences and clinical research.
Partner Organizations
Curavit News
